Related Experiment Video

Updated: Jun 20, 2026

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus (MRSA) in Rat
07:46

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus (MRSA) in Rat

Published on: June 4, 2012

Major cerebral events in Staphylococcus aureus infective endocarditis: is anticoagulant therapy safe?

Rasmus V Rasmussen1, Ulrika Snygg-Martin, Lars Olaison

  • 1Department of Cardiology, Gentofte University Hospital, Copenhagen, Denmark. ravera02@geh.regionh.dk

Cardiology
|August 20, 2009
PubMed

Insights

Anticoagulation may reduce the risk of major cerebral events in patients with Staphylococcus aureus infective endocarditis (IE). This study found no increased risk of cerebral hemorrhage with anticoagulation in these patients.

Area of Science:

  • Cardiology
  • Neurology
  • Infectious Diseases

Background:

  • Left-sided Staphylococcus aureus infective endocarditis (IE) poses a significant risk of major cerebral events.
  • The role of anticoagulation in managing these events remains a critical clinical question.

Purpose of the Study:

  • To investigate the impact of anticoagulation on major cerebral events in patients diagnosed with left-sided Staphylococcus aureus IE.
  • To assess the safety and efficacy of anticoagulation in this patient population.

Main Methods:

  • A prospective cohort study design was employed.
  • The use of anticoagulation was evaluated in relation to major cerebral events at admission and during hospitalization.

Main Results:

  • 40% of patients experienced major cerebral events, with ischemic stroke being the most common.
  • Patients on anticoagulation had a significantly lower incidence of major cerebral events at admission (15% vs. 37%).
  • No increased risk of cerebral hemorrhage was observed in patients receiving anticoagulation.

Conclusions:

  • Anticoagulation is not associated with an increased risk of cerebral hemorrhage in Staphylococcus aureus IE.
  • Anticoagulation demonstrated a reduced risk of cerebral events prior to antibiotic initiation.
  • Current data support the continued use of anticoagulation in Staphylococcus aureus IE when clinically indicated.
Abstract

More Related Videos

In Vitro and In Vivo Model to Study Bacterial Adhesion to the Vessel Wall Under Flow Conditions10:24

In Vitro and In Vivo Model to Study Bacterial Adhesion to the Vessel Wall Under Flow Conditions

Published on: June 11, 2015

Related Concept Videos

Endocarditis I: Introduction01:25

Endocarditis I: Introduction

Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...